Here, we show that MAG:PLP1 and PDGFRβ were significantly reduced, at an early stage i.e. BSIII–IV, in Alzheimer’s disease indicating vascular dysfunction from an early to intermediate stage of disease. Here, MAG is linked to Alzheimer disease.